Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings

被引：27

作者：

Eratne, Dhamidhu ^{[1
,2
,3
,4
]}

Loi, Samantha M. ^{[1
,2
,3
,4
]}

Qiao-Xin Li ^{[4
]}

Stehmann, Christiane ^{[4
,5
,6
]}

Malpas, Charles B. ^{[7
]}

Santillo, Alexander ^{[8
,9
]}

Janelidze, Shorena ^{[8
,9
]}

Cadwallader, Claire ^{[1
]}

Walia, Nirbaanjot ^{[1
]}

Ney, Blair ^{[10
,11
]}

Lewis, Victoria ^{[5
,6
]}

Senesi, Matteo ^{[5
,6
]}

Fowler, Christopher ^{[10
]}

McGlade, Amelia ^{[4
]}

Varghese, Shiji ^{[4
]}

Ravanfar, Parsa ^{[1
,2
,3
]}

Kelso, Wendy ^{[1
]}

Farrand, Sarah ^{[1
,2
,3
]}

Keem, Michael ^{[1
]}

Kang, Matthew ^{[1
]}

Goh, Anita M. Y. ^{[1
,2
,3
]}

Dhiman, Kunal ^{[12
,13
]}

Gupta, Veer ^{[12
,13
]}

Watson, Rosie ^{[14
]}

Yassi, Nawaf ^{[14
,15
,16
]}

Kaylor-Hughes, Cath ^{[17
]}

Kanaan, Richard ^{[18
]}

Perucca, Piero ^{[19
,20
,21
]}

Dobson, Hannah ^{[1
,22
]}

Vivash, Lucy ^{[21
]}

Ali, Rashida ^{[21
]}

O'Brien, Terence J. ^{[21
]}

Hansson, Oskar ^{[8
,9
]}

Zetterberg, Henrik ^{[23
,24
,25
,26
]}

Blennow, Kaj ^{[23
,24
]}

Walterfang, Mark ^{[1
,2
,3
,10
]}

Masters, Colin L. ^{[4
]}

Berkovic, Samuel F. ^{[27
]}

Collins, Steven ^{[5
,6
]}

Velakoulis, Dennis ^{[1
,2
,3
]}

机构：

[1] Royal Melbourne Hosp, Neuropsychiat, 300 Grattan St, Parkville, Vic 3050, Australia

[2] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia

[3] Univ Melbourne, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia

[4] Florey Inst Neurosci & Mental Hlth, Natl Dementia Diagnost Lab, Parkville, Vic, Australia

[5] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Australian Natl Creutzfeldt Jakob Dis Registry, Parkville, Vic, Australia

[6] Univ Melbourne, Dept Med, Parkville, Vic, Australia

[7] Royal Melbourne Hosp, Dept Med, Dept Neurol, Clin Outcomes Res Unit CORe, Parkville, Vic, Australia

[8] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Lund, Sweden

[9] Skane Univ Hosp, Memory Clin, Malmo, Sweden

[10] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia

[11] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia

[12] Deakin Univ, Sch Med, Geelong, Vic, Australia

[13] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia

[14] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia

[15] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Royal Melbourne Hosp, Parkville, Vic, Australia

[16] Univ Melbourne, Melbourne Brain Ctr, Dept Neurol, Royal Melbourne Hosp, Parkville, Vic, Australia

[17] Univ Melbourne, Dept Gen Practice, Integrated Mental Hlth Team, Parkville, Vic, Australia

[18] Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia

[19] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia

[20] Univ Melbourne, Austin Hlth, Comprehens Epilepsy Program, Heidelberg, Vic, Australia

[21] Monash Univ, Alfred Hosp, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia

[22] Alfred Hlth, Dept Psychiat, Melbourne, Vic, Australia

[23] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden

[24] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

[25] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England

[26] UCL, UK Dementia Res Inst, London, England

[27] Univ Melbourne, Epilepsy Res Ctr, Dept Med, Austin Hlth, Heidelberg, Vic, Australia

来源：

ALZHEIMERS & DEMENTIA | 2022年 / 18卷 / 11期

基金：

英国医学研究理事会; 瑞典研究理事会; 澳大利亚国家健康与医学研究理事会;

关键词：

biomarker; dementia; diagnosis; neurofilament; neurology; psychiatric disorders; psychiatry; CREUTZFELDT-JAKOB-DISEASE; NEURODEGENERATIVE DEMENTIA; DIAGNOSTIC-ACCURACY; BIOMARKERS; TAU; CSF; PATHOLOGY; SEVERITY; PROTEIN;

D O I：

10.1002/alz.12549

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction Many patients with cognitive and neuropsychiatric symptoms face diagnostic delay and misdiagnosis. We investigated whether cerebrospinal fluid (CSF) neurofilament light (NfL) and total-tau (t-tau) could assist in the clinical scenario of differentiating neurodegenerative (ND) from psychiatric disorders (PSY), and rapidly progressive disorders. Methods Biomarkers were examined in patients from specialist services (ND and PSY) and a national Creutzfeldt-Jakob registry (Creutzfeldt-Jakob disease [CJD] and rapidly progressive dementias/atypically rapid variants of common ND, RapidND). Results A total of 498 participants were included: 197 ND, 67 PSY, 161 CJD, 48 RapidND, and 20 controls. NfL was elevated in ND compared to PSY and controls, with highest levels in CJD and RapidND. NfL distinguished ND from PSY with 95%/78% positive/negative predictive value, 92%/87% sensitivity/specificity, 91% accuracy. NfL outperformed t-tau in most real-life clinical diagnostic dilemma scenarios, except distinguishing CJD from RapidND. Discussion We demonstrated strong generalizable evidence for the diagnostic utility of CSF NfL in differentiating ND from psychiatric disorders, with high accuracy.

引用

页码：2218 / 2233

页数：16

共 50 条

[41] Plasma Total α-Synuclein and Neurofilament Light Chain: Clinical Validation for Discriminating Parkinson's Disease from Normal Control
Lin, Wei-Che
Lu, Cheng-Hsien
Chiu, Pai-Yi
Yang, Shieh-Yueh
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2021, 49 (04) : 401 - 409
[42] The ELISA-Measured Increase in Cerebrospinal Fluid Tau that Discriminates Alzheimer's Disease from other Neurodegenerative Disorders is not Attributable to Differential Recognition of Tau Assembly Forms
O'Dowd, Sean T.
Ardah, Mustafa T.
Johansson, Per
Lomakin, Aleksey
Benedek, George B.
Roberts, Kinley A.
Cummins, Gemma
El Agnaf, Omar M.
Svensson, Johan
Zetterberg, Henrik
Lynch, Timothy
Walsh, Dominic M.
JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (04) : 923 - 928
[43] Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer's Disease with Different Rate of Progression (RoP): A Preliminary Study
Blandino, Valeria
Colletti, Tiziana
Ribisi, Paolo
Tarantino, Domenico
Mosca, Viviana
Agnello, Luisa
Ciaccio, Marcello
Piccoli, Tommaso
BRAIN SCIENCES, 2024, 14 (10)
[44] Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis
Sako, Wataru
Murakami, Nagahisa
Izumi, Yuishin
Kaji, Ryuji
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 352 (1-2) : 84 - 87
[45] A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
Das, Shreyasee
Dewit, Nele
Jacobs, Dirk
Pijnenburg, Yolande A. L.
In't Veld, Sjors G. J. G.
Coppens, Salome
Quaglia, Milena
Hirtz, Christophe
Teunissen, Charlotte E.
Vanmechelen, Eugeen
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[46] A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds
Skoog, Ingmar
Kern, Silke
Najar, Jenna
Guerreiro, Rita
Bras, Jose
Waern, Margda
Zetterberg, Henrik
Blennow, Kaj
Zettergren, Anna
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (06): : 983 - 990
[47] Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia
Mendez-Barrio, Carlota
Medina-Rodriguez, Manuel
Mendoza-Vazquez, Gonzalo
Garcia-Roldan, Ernesto
Rodrigo-Herrero, Silvia
Luque-Tirado, Andrea
Almodovar-Sierra, Angela
Franco-Macias, Emilio
JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (03) : 877 - 887
[48] Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis
Kou, Wenyi
Li, Siming
Yan, Rui
Zhang, Junjiao
Wan, Zhirong
Feng, Tao
JOURNAL OF NEUROLOGY, 2025, 272 (04)
[49] Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: Multicenter study in Japan
Nishimura, T
Takeda, M
Nakamura, Y
Yosbida, Y
Arai, H
Sasaki, H
Shouji, M
Hirai, S
Khise, K
Tanaka, K
Hamamoto, M
Yamamoto, H
Matsubayashi, T
Urakami, K
Adachi, Y
Nakashima, K
Toji, H
Nakamura, S
Yoshida, H
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (03): : 227 - 235
[50] Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years
Darmanthe, Nicolas
Tabatabaei-Jafari, Hossein
Cherbuin, Nicolas
JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (03) : 951 - 964

← 1 2 3 4 5 →